These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20134268)

  • 21. A phase I study of TRC105 anti-endoglin (CD105) antibody in metastatic castration-resistant prostate cancer.
    Karzai FH; Apolo AB; Cao L; Madan RA; Adelberg DE; Parnes H; McLeod DG; Harold N; Peer C; Yu Y; Tomita Y; Lee MJ; Lee S; Trepel JB; Gulley JL; Figg WD; Dahut WL
    BJU Int; 2015 Oct; 116(4):546-55. PubMed ID: 25407442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of serum transforming growth factor-alpha in patients of primary epithelial ovarian cancers by enzyme immunoassay.
    Chien CH; Huang CC; Lin YH; Shen J; Chow SN
    Gynecol Oncol; 1997 Sep; 66(3):405-10. PubMed ID: 9299253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transforming growth factor-beta1 and CD105 promote the migration of hepatocellular carcinoma-derived endothelium.
    Benetti A; Berenzi A; Gambarotti M; Garrafa E; Gelati M; Dessy E; Portolani N; Piardi T; Giulini SM; Caruso A; Invernici G; Parati EA; Nicosia R; Alessandri G
    Cancer Res; 2008 Oct; 68(20):8626-34. PubMed ID: 18922939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High immunohistochemical expression of TGF-β1 predicts a poor prognosis in cervical cancer patients who harbor enriched endoglin microvessel density.
    Lin H; Huang CC; Ou YC; Huang EY; Changchien CC; Tseng CW; Fu HC; Wu CH; Li CJ; Ma YY
    Int J Gynecol Pathol; 2012 Sep; 31(5):482-9. PubMed ID: 22833091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High serum levels of vascular endothelial growth factor-A and transforming growth factor-β1 before neoadjuvant chemoradiotherapy predict poor outcomes in patients with esophageal squamous cell carcinoma receiving combined modality therapy.
    Cheng JC; Graber MS; Hsu FM; Tsai CL; Castaneda L; Lee JM; Chang DT; Koong AC
    Ann Surg Oncol; 2014 Jul; 21(7):2361-8. PubMed ID: 24623035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and structural features of endoglin (CD105), a transforming growth factor beta1 and beta3 binding protein, in human melanoma.
    Altomonte M; Montagner R; Fonsatti E; Colizzi F; Cattarossi I; Brasoveanu LI; Nicotra MR; Cattelan A; Natali PG; Maio M
    Br J Cancer; 1996 Nov; 74(10):1586-91. PubMed ID: 8932339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TNF alpha down-regulates CD105 expression in vascular endothelial cells: a comparative study with TGF beta 1.
    Li C; Guo B; Ding S; Rius C; Langa C; Kumar P; Bernabeu C; Kumar S
    Anticancer Res; 2003; 23(2B):1189-96. PubMed ID: 12820370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.
    Tanaka F; Otake Y; Yanagihara K; Kawano Y; Miyahara R; Li M; Yamada T; Hanaoka N; Inui K; Wada H
    Clin Cancer Res; 2001 Nov; 7(11):3410-5. PubMed ID: 11705856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival.
    Chen CA; Cheng WF; Lee CN; Chen TM; Kung CC; Hsieh FJ; Hsieh CY
    Gynecol Oncol; 1999 Aug; 74(2):235-40. PubMed ID: 10419737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF.
    Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y
    Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transforming growth factor-β1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation.
    Tal R; Seifer DB; Shohat-Tal A; Grazi RV; Malter HE
    Fertil Steril; 2013 Aug; 100(2):538-43. PubMed ID: 23684116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transforming growth factor-beta binding receptor endoglin (CD105) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence.
    Bellone G; Solerio D; Chiusa L; Brondino G; Carbone A; Prati A; Scirelli T; Camandona M; Palestro G; Dei Poli M
    Ann Surg Oncol; 2007 Nov; 14(11):3232-42. PubMed ID: 17682823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased serum level of epidermal growth factor receptor (EGFR) is associated with poor progression-free survival in patients with epithelial ovarian cancer.
    Tas F; Karabulut S; Serilmez M; Ciftci R; Duranyildiz D
    Cancer Chemother Pharmacol; 2014 Mar; 73(3):631-7. PubMed ID: 24477605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble endoglin and transforming growth factor-β₁ and the development of vasospasm after spontaneous subarachnoid hemorrhage: a pilot study.
    Dietmann A; Lackner P; Fischer M; Broessner G; Pfausler B; Helbok R; Schmutzhard E; Beer R
    Cerebrovasc Dis; 2012; 33(1):16-22. PubMed ID: 22133666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathologic significance of CD105 expression in squamous cell carcinoma of the hypopharynx.
    Chien CY; Su CY; Hwang CF; Chuang HC; Hsiao YC; Wu SL; Huang CC
    Head Neck; 2006 May; 28(5):441-6. PubMed ID: 16320363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High expression of CD105 as a prognostic predictor of early tongue cancer.
    Chuang HC; Su CY; Huang HY; Chien CY; Chen CM; Huang CC
    Laryngoscope; 2006 Jul; 116(7):1175-9. PubMed ID: 16826056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of endoglin (CD105) in cervical cancer.
    Zijlmans HJ; Fleuren GJ; Hazelbag S; Sier CF; Dreef EJ; Kenter GG; Gorter A
    Br J Cancer; 2009 May; 100(10):1617-26. PubMed ID: 19352388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
    Bamias A; Koutsoukou V; Terpos E; Tsiatas ML; Liakos C; Tsitsilonis O; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Papatheodoridis G; Archimandritis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2008 Feb; 108(2):421-7. PubMed ID: 18036640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in esophageal adenocarcinoma.
    Saad RS; El-Gohary Y; Memari E; Liu YL; Silverman JF
    Hum Pathol; 2005 Sep; 36(9):955-61. PubMed ID: 16153457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum relaxin as a diagnostic and prognostic marker in patients with epithelial ovarian cancer.
    Guo X; Liu Y; Huang X; Wang Y; Qu J; Lv Y
    Cancer Biomark; 2017 Dec; 21(1):81-87. PubMed ID: 29060928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.